亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Mechanical thrombectomy for the treatment of primary and secondary distal medium-vessel occlusion stroke: systematic review and meta-analysis

医学 冲程(发动机) 荟萃分析 溶栓 置信区间 改良兰金量表 脑出血 闭塞 子群分析 内科学 外科 心肌梗塞 缺血性中风 缺血 蛛网膜下腔出血 工程类 机械工程
作者
Aarón Rodríguez-Calienes,Juan Vivanco‐Suarez,J Sequeiros,Milagros Galecio‐Castillo,Cynthia Zevallos,Mudassir Farooqui,Santiago Ortega‐Gutiérrez
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:15 (e3): e460-e467 被引量:22
标识
DOI:10.1136/jnis-2022-019975
摘要

There is limited evidence on the indication and role of mechanical thrombectomy (MT) in patients with distal medium-vessel occlusions (DMVOs). The aim of this systematic review and meta-analysis was to evaluate all the evidence available on the efficacy and safety of MT techniques (stent retriever, aspiration) in primary and secondary DMVOs.Five databases were searched from inception to January 2023 for studies of MT in primary and secondary DMVOs. Outcomes of interest included favorable functional outcome (90-day modified Rankin scale (mRS) 0-2), successful reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) 2b-3), symptomatic intracerebral hemorrhage (sICH), and 90-day mortality. Prespecified subgroup meta-analyses according to the specific MT technique and to the vascular territory (distal M2-M5, A2-A5, P2-P5) were also performed.A total of 29 studies with 1262 patients were included. For primary DMVOs (n=971 patients), pooled rates of successful reperfusion, favorable outcome, 90-day mortality and sICH were 84% (95% confidence interval (CI) 76 to 90%), 64% (95% CI 54 to 72%), 12% (95% CI 8 to 18%), and 6% (95% CI 4 to 10%), respectively. For secondary DMVOs (n=291 patients), pooled rates of successful reperfusion, favorable outcome, 90-day mortality and sICH were 82% (95% CI 73 to 88%), 54% (95% CI 39 to 69%), 11% (95% CI 5 to 20%), and 3% (95% CI 1 to 9%), respectively. Subgroup analyses by MT technique and by vascular territory showed no differences in primary and secondary DMVOs.Our findings suggest that MT using aspiration or stent retriever techniques appears to be effective and safe in primary and secondary DMVOs. However, given the level of evidence of our results, further confirmation in well-designed randomized controlled trials is needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Faye完成签到,获得积分10
10秒前
李剑鸿发布了新的文献求助50
15秒前
Faye发布了新的文献求助10
21秒前
隐形曼青应助幽默赛君采纳,获得100
23秒前
搜集达人应助科研通管家采纳,获得10
50秒前
田様应助科研通管家采纳,获得10
51秒前
思源应助科研通管家采纳,获得10
51秒前
1分钟前
辛勤幻梅发布了新的文献求助10
1分钟前
彭于晏应助spark810采纳,获得10
1分钟前
可罗雀完成签到,获得积分10
1分钟前
Lionnn完成签到 ,获得积分10
2分钟前
tao完成签到 ,获得积分10
2分钟前
Eatanicecube完成签到,获得积分10
2分钟前
2分钟前
spark810发布了新的文献求助10
2分钟前
Lucas应助听山不是海采纳,获得10
2分钟前
可爱的函函应助www采纳,获得10
2分钟前
2分钟前
2分钟前
www发布了新的文献求助10
3分钟前
3分钟前
3分钟前
3分钟前
3分钟前
Lionnn发布了新的文献求助10
3分钟前
4分钟前
Aquilus发布了新的文献求助10
4分钟前
Flash发布了新的文献求助10
4分钟前
konosuba完成签到,获得积分10
4分钟前
Lionnn发布了新的文献求助10
4分钟前
听山不是海完成签到,获得积分20
4分钟前
5分钟前
5分钟前
Kkk完成签到 ,获得积分10
5分钟前
林利芳完成签到 ,获得积分10
5分钟前
王福栋发布了新的文献求助10
6分钟前
dolphin完成签到 ,获得积分0
7分钟前
7分钟前
幽默赛君发布了新的文献求助100
7分钟前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3146717
求助须知:如何正确求助?哪些是违规求助? 2798015
关于积分的说明 7826552
捐赠科研通 2454530
什么是DOI,文献DOI怎么找? 1306360
科研通“疑难数据库(出版商)”最低求助积分说明 627704
版权声明 601522